Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yu V Trinitatskiy"'
Publikováno v:
Practical medicine. 18:69-75
To optimize the management of patients with familial multiple sclerosis (MS) by identifying the clinical and epidemiological features of the disease course. Material and methods. The object of the study was 2253 patients with clinically reliable MS a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78bf8187760079d935e4623c60260716
https://doi.org/10.32000/2072-1757-2020-5-69-75
https://doi.org/10.32000/2072-1757-2020-5-69-75
Autor:
D V Sazonov, L I Volkova, O P Patrusheva, L V Chichanovskaya, A V Zinkina-Orikhan, Kotov Sv, M A Sherman, M N Zakharova, T I Negrich, F. A. Khabirov, Yu V Trinitatskiy, L P Bosenko, A N Boyko, P. V. Timchenko, K B Tursunova, E V Parshina, M Ya Khavunka, Yu N Lin'kova, E V Lekomtseva, S. V. Prokopenko, V V Vasilovskiy
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117(2. Vyp. 2)
To prove the equivalent efficacy of teberif (BCD-033, interferon beta-1) and rebif (interferon beta-1a) in patients with remitting multiple sclerosis (RMS).A multicenter double blind placebo-controlled comparative randomized III phase study included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93d0210c2394ef5581b6be0957c7270
https://pubmed.ncbi.nlm.nih.gov/28617368
https://pubmed.ncbi.nlm.nih.gov/28617368
Autor:
F. A. Khabirov, M Ya Khavunka, T I Negrich, E V Lekomtseva, Yu V Trinitatskiy, L I Volkova, S. V. Prokopenko, V V Vasilovskiy, E Yu Stukalina, D V Sazonov, O P Patrusheva, Kotov Sv, M A Sherman, A V Zinkina-Orikhan, L V Timchenko, E V Parshina, L P Bosenko, A N Boyko, L V Chichanovskaya, Yu N Lin'kova, M N Zakharova, I G Obukhova, Roman Ivanov
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 119:73
To evaluate efficacy, safety, and tolerability of the treatment with teberif/interferon β-1a, to analyze safety, tolerability and dynamics of key efficacy variables after switching from referent drug rebif to biosimilar teberif in patients with remi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46019bc35b7ad16dd208a674713fb402
https://doi.org/10.17116/jnevro20191192273
https://doi.org/10.17116/jnevro20191192273